Latest Partnerships News

Page 13 of 746
Ocean Sciences has committed A$100,000 to a 12-month research program testing whether Sargassum-derived alginate can recover gold, silver and potentially rare earth elements from retired data centre hardware. The project gives the seaweed company a new industrial angle, but remains firmly at the laboratory stage.
Victor Sage
Victor Sage
28 Oct 2026
Avecho has resumed recruitment for the final cohort of its pivotal Phase III insomnia trial after an interim review supported continuing at the original 519-participant target. The biotechnology company is also pursuing international licensing while holding $5.3 million in cash.
Ada Torres
Ada Torres
28 Oct 2026
Cazaly Resources has secured a 51% stake in the Goongarrie Gold Project a year ahead of schedule, while early Hastings drilling extended anomalous gold mineralisation along the Bardoc Tectonic Zone. The explorer is now testing another historical target at Gulls Blow as a new managing director begins a review of the wider portfolio.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Nico Resources has completed about 70% of a 6,000-metre infill drilling program at its Wingellina nickel-cobalt project, with initial assays expected in November. The technical progress comes as nickel and cobalt prices weaken and a proposed downstream partnership remains non-binding.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Perpetual Resources has expanded its Nevada Scheelite tungsten project more than 15-fold and reported selective underground samples grading up to 12.03% WO₃. The exploration momentum comes with a sharper funding question, with A$1.639 million in cash and an estimated 2.37 quarters of funding at 30 September.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Archer Materials has moved its IonQ relationship into early commercial activity and advanced its Biochip towards external testing, but its graphene spin qubit demonstration is taking longer than expected. The company ended September with $A13.0 million in cash and an estimated 4.68 quarters of funding at its quarterly operating burn.
Victor Sage
Victor Sage
28 Oct 2026
Amplia Therapeutics is preparing the next stage of narmafotinib’s pancreatic cancer development as its ACCENT trial nears completion and a Lilly collaboration broadens the drug’s potential into lung cancer. The biotech ended September with $20.8 million in cash, rising to $25.6 million pro forma after an October R&D tax refund.
Victor Sage
Victor Sage
28 Oct 2026
Clever Culture Systems has fully invoiced three APAS Independence sales in the first quarter of FY27 and expects customer commitments to lift first-half sales and evaluations to eight instruments. A new paid evaluation with a Top-20 pharmaceutical company could expand its base of major drugmakers to nine, although several milestones remain prospective.
Victor Sage
Victor Sage
28 Oct 2026
Vitrafy has expanded its US blood and cell therapy partnerships while preparing Guardion for a planned medical device listing by the end of 2026. The company ended September with A$38.3 million in cash and term deposits, but expects spending to rise as validation and manufacturing accelerate.
Victor Sage
Victor Sage
28 Oct 2026
Aquirian has begun mobilising at Brightstar Resources’ Lord Byron site and started a $200,000 grade control drilling program. The work is the first operational step under a broader three-year contract valued at approximately $48 million.
Victor Sage
Victor Sage
28 Oct 2026
Yari Resources has completed the Arcadia acquisition, lifting its combined reported Queensland coal resources to 504.9Mt and materially increasing its Indicated inventory. The enlarged portfolio brings product flexibility and infrastructure access, but also leaves Yari with technical work, contingent obligations and roughly two quarters of cash funding.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Encounter Resources has grown its Aileron niobium resource by 54% to 120 million tonnes while moving the West Arunta project into mining lease, metallurgical and development work. The company also ended FY2026 with $26.9 million in cash and term deposits, but still has no Ore Reserves or operating revenue base.
Maxwell Dee
Maxwell Dee
27 Oct 2026

Browse the archive

Full archive